Insight Molecular (IMDX): Wutah pendapatan triwulanan

Simbol lan logo merek imdxinc.com (IMDX)

Geopolitical strife is hindering global testing for Insight Molecular Diagnostics (IMDX), as reflected in the current chart on GURU.Markets, where the quarter-over-quarter revenue growth rate currently stands at 115.10. The business relies on insurance deals and oncologist loyalty despite FDA rigidity. High barriers to entry are created by patents and strict CLIA standards, which limit the access of new players to the niche.

IMDX (Insight Molecular) riwayat Owah-owahan pendapatan dibandhingake kuartal kepungkur saka 19.06.2025 nganti 20.11.2026

imdxinc.com (IMDX) - rincian metrik lan laporan keuangan

Analisis umum perusahaan:IMDX - Insight Molecular
Barang unggulan Insight Molecular Diagnostics

The development of molecular tests in collaboration with oncology centers directly determines the scaling pace of Insight Molecular Diagnostics (IMDX). By analyzing the quarterly sales growth rate, investors assess the percentage change in revenue for the current quarter relative to the previous one, which helps identify cash flow stability and confirm the company's fundamental reliability amid shifting market conditions.

Analisis pesaing

A - Wutah pendapatan kuartal marang kuartal|Tingkat wutah dodolan sajrone kuartal Quest Diagnostics Incorporated DGX|ILMN (illumina.com) - Wutah dodolan triwulanan|Wutah dodolan triwulanan Cologuard|RVTY (Revvity Corp) - Wutah pendapatan triwulanan|Wutah pendapatan triwulanan Bio-Rad Laboratories Inc|Wutah dodolan triwulanan NNNN (Anbio Biotechnology)|SHC (Sotera Health Company) - Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal QuidelOrtho Inc. QDEL|Wutah pendapatan triwulanan OPKO Health Inc OPK|CareDx Inc - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan MRVI (Maravai)|FLGT: Wutah pendapatan triwulanan|LAB (Standard BioTools Inc.) - Wutah pendapatan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal Cytek Biosciences Inc|Tingkat wutah pendapatan sajrone kuartal OraSure OSUR|Wutah dodolan triwulanan XGN (Exagen Diagnostics)|Tingkat wutah dodolan sajrone kuartal MDxHealth Inc.|Wutah pendapatan kuartal marang kuartal Lucid Diagnostics, Inc. LUCD|Prenetics Global Ltd (PRE) - Tingkat wutah pendapatan sajrone kuartal|Trinity Biotech Corp - Wutah pendapatan triwulanan|Tingkat wutah dodolan sajrone kuartal ProPhase PRPH|AIMD: Wutah pendapatan triwulanan|CODX - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal Heart Test Laboratories, Inc.|Wutah pendapatan kuartal marang kuartal BMRA|Wutah pendapatan triwulanan CDIO|Onconetix - Wutah dodolan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal viraxbiolabs.com VRAX|Tingkat wutah dodolan sajrone kuartal Bluejay (BJDX)|AWH: Wutah dodolan triwulanan|Tingkat wutah dodolan sajrone kuartal Accelerate Diagnostics, Inc. AXDX|Centogene (CNTG) - Wutah pendapatan kuartal marang kuartal|Dinamika pendapatan kuartal marang kuartal ENZ (Enzo)|Wutah dodolan kuartal marang kuartal Fresh2 (FRES)|Genetic Technologies (GENE) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan ME|Wutah pendapatan kuartal marang kuartal PMD (Psychemedics Corporation)